The drug landscape has changed with an increasingly toxic supply since the Canadian Drugs and Substances Strategy was first developed in 2016, Health Canada said Monday.
The only cure for painful sickle cell disease today is a bone marrow transplant. But soon there may be a new cure that attacks the disorder at its genetic source.
